Cinven set to acquire Mercury Pharma from HgCapital

Private equity company Cinven is to acquire Mercury Pharma, an international pharmaceutical organisation that markets niche and branded treatments for thyroid disorders, pain, arthritis, pulmonary arterial hypertension and cardiovascular diseases, from HgCapital.

Croydon-based Mercury Pharma also markets a range of anaesthesia products.

The company’s products are sold in more than 50 countries, with a strong focus on the UK.